Mental health systems in the US and UK have entered [...]

Alto Neuroscience has strengthened its intellectual property position around its [...]

A genetically targeted approach to depression treatment has shown promising [...]

Cybin’s lead psychedelic-based candidate CYB003, designed as an adjunctive treatment [...]

As psychedelic-assisted therapies move closer to mainstream psychiatric care, Cybin, [...]